Crossmark

The critical role of QM/MM X-ray refinement and accurate tautomer/protomer determination in structure-based drug design

Published Online: 2020-10-27

Published Print: 2021-04

Authors

Borbulevych, Oleg Y.

Martin, Roger I.

Westerhoff, Lance M. https://orcid.org/0000-0001-8092-6919
Funding

Funding for this research was provided by:

National Institute of General Medical Sciences (R43GM113555)

National Institute of General Medical Sciences (R44GM079899)

National Institute of General Medical Sciences (R44GM121162)
License Information

Text and Data Mining valid from 2020-10-27

Version of Record valid from 2020-10-27
More Information

Article History

Received: 17 June 2020

Accepted: 12 October 2020

First Online: 27 October 2020

Document is current